Home

Home

The high cost of bipolar disorder

The most expensive behavioural healthcare diagnosis, for sufferers and their insurers, is bipolar disorder, according to a study published in the American Journal of Psychiatry (160:1286-1290, July 2003).

For every behavioural healthcare dollar spent on outpatient care for those with this disorder, $1.80 is spent on inpatient care, say the researchers, adding that this suggests that better prevention management could decrease the financial burden of bipolar disorder.

The researchers examined insurance claims from 1996 from about 1.66 million people. The average annual charges per person and payments for behavioural healthcare were calculated along with patient’s out-of-pocket expenses and in-patient hospital admission rates.

Behavioural healthcare expenditures for bipolar disorder were compared to expenditures for other behavioural healthcare diagnoses in the same insurance plans. The researchers found that 7.5% of all covered individuals filed a behavioural healthcare claim. Of those, 3.0% were identified as having bipolar disorder, but they accounted for 12.4% of total plan expenditures. Patients with bipolar disorder incurred annual out-of-pocket expenses of $568, over double the $232 incurred by all claimants. The in-patient hospital admission rate for patients with bipolar disorder was also higher (39.1%) compared with 4.5% for all other behavioural healthcare claimants. Additionally, annual insurance payments were higher for covered medical services for individuals with bipolar disorder than for patients with other behavioural healthcare diagnoses.

Full details: http://ajp.psychiatryonline.org/cgi/content/abstract/160/7/1286

This article was published on 07/01/2003

Search

 

Service

Company News

EH 6/08 as E-paper

Our latest issue of EUROPEAN HOSPITAL, EH 6/2008, is once again chock full of great articles, for example a feature on a Czech health spa located in the beautiful Carpathian Mountains and another management special on healthcare for Muslim patients across Europe. But Europe is not enough: you will get a first-hand assessment of RSNA 2008, the Annual Meeting of the Radiological Society of North America, which took place in Chicago, and we are presenting an ambitious project by US oncologists to provide access to advanced diagnostics and radiotherapy treatments in developing countries.